Trump, prescription drug
Digest more
3h
NewsNation on MSNHere are 8 FDA-approved medications for weight lossAs medications become increasingly popular to support weight loss, not all of them are approved by the U.S. Food and Drug Administration. Most prescription weight-loss drugs work by making you feel less hungry or fuller.
Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.
According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, and the effects are impressive. A 2022 study found that people who received weekly semaglutide injections lost an average of about 15 pounds after three months.
22hon MSN
President Donald Trump signed an executive order Monday that is aimed at lowering the costs of prescription drugs as Americans pay more for medications than their neighbors.
If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your quality of life, and that should also be considered, according to Dr. Richa Mittal, an obesity medicine doctor and owner of Radiant Health Weight Loss and Wellness in Frisco, Texas.
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily make copies of Novo Nordisk’s semaglutide. The gambit boosted the telehealth firm’s stock price,
President Donald Trump signed an executive order on Monday aimed at slashing prescription drug prices in the U.S. that could lead to the capping of prices at a level equivalent to the cost in
Are you a fan of this popular spice? A doctor explains why sprinkling cinnamon in your coffee is probably OK, but taking daily cinnamon supplements likely isn’t.
There’s growing hope that weight loss injections like Wegovy and Mounjaro could soon be available at your local pharmacy for the standard NHS prescription price of just £9.90. Right now, these medications can cost upwards of £150 privately, making them out of reach for many. But new plans could change that.
Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.
CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of insurance-imposed limits that disrupt treatment.